US Stock MarketDetailed Quotes

Haemonetics (HAE)

Watchlist
  • 70.020
  • -0.090-0.13%
Close Jan 22 15:59 ET
  • 70.020
  • 0.0000.00%
Post 16:10 ET
3.28BMarket Cap20.47P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Haemonetics (HAE) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Sep 27, 2025
(Q1)Jun 28, 2025
(FY)Mar 29, 2025
(Q4)Mar 29, 2025
(Q3)Dec 28, 2024
(Q2)Sep 28, 2024
(Q1)Jun 29, 2024
(FY)Mar 30, 2024
(Q4)Mar 30, 2024
(Q3)Dec 30, 2023
Total revenue
-5.27%327.32M
-4.40%321.39M
3.95%1.36B
-3.70%330.6M
3.66%348.54M
8.59%345.51M
7.98%336.17M
12.01%1.31B
12.77%343.29M
10.14%336.25M
Operating revenue
-5.27%327.32M
-4.40%321.39M
3.95%1.36B
-3.70%330.6M
3.66%348.54M
8.59%345.51M
7.98%336.17M
12.01%1.31B
12.77%343.29M
10.14%336.25M
Cost of revenue
-16.13%132.57M
-19.91%129.15M
-0.91%611.87M
-17.82%137.55M
-2.14%155M
7.04%158.07M
11.93%161.25M
11.55%617.51M
12.97%167.38M
8.04%158.38M
Gross profit
3.90%194.74M
9.90%192.24M
8.30%748.96M
9.75%193.05M
8.82%193.55M
9.93%187.44M
4.58%174.92M
12.43%691.55M
12.58%175.91M
12.07%177.87M
Operating expense
-4.26%127.67M
2.37%138.37M
5.70%547.77M
3.49%142.35M
1.99%134.52M
-1.37%133.35M
18.98%135.17M
12.80%518.25M
13.32%137.54M
14.26%131.89M
Selling and administrative expenses
-4.98%101.62M
2.28%110.72M
1.16%436.79M
3.48%115.14M
-4.70%106.46M
-7.26%106.95M
15.79%108.25M
14.63%431.78M
13.81%111.26M
18.01%111.71M
Research and development costs
5.18%14.87M
12.54%16.26M
15.22%62.72M
0.36%15.91M
19.33%15.83M
11.64%14.14M
14.24%14.45M
8.59%54.44M
1.36%15.86M
4.54%13.27M
Depreciation amortization depletion
-8.82%11.18M
-8.65%11.39M
50.67%48.26M
8.35%11.3M
76.96%12.23M
69.81%12.26M
66.88%12.47M
-1.87%32.03M
30.74%10.43M
-14.45%6.91M
-Depreciation and amortization
-8.82%11.18M
-8.65%11.39M
50.67%48.26M
8.35%11.3M
76.96%12.23M
69.81%12.26M
66.88%12.47M
-1.87%32.03M
30.74%10.43M
-14.45%6.91M
Operating profit
24.01%67.08M
35.51%53.87M
16.09%201.19M
32.17%50.7M
28.39%59.03M
53.21%54.09M
-25.91%39.76M
11.34%173.3M
10.00%38.36M
6.24%45.98M
Net non-operating interest income expense
-3.05%-7.21M
-225.10%-8.7M
25.13%-9.75M
90.84%-598K
-367.52%-9.11M
-183.00%-6.99M
436.25%6.96M
11.02%-13.02M
-148.35%-6.53M
-84.74%-1.95M
Non-operating interest income
----
----
----
----
----
----
--6.96M
----
----
----
Non-operating interest expense
3.05%7.21M
--8.7M
-25.13%9.75M
-90.84%598K
367.52%9.11M
183.00%6.99M
----
-11.02%13.02M
148.35%6.53M
84.74%1.95M
Other net income (expense)
-259.01%-8.58M
345.05%20.63M
-2.39M
-2,303.93%-8.42M
Special income (charges)
-259.01%-8.58M
----
345.05%20.63M
----
----
---2.39M
----
-2,303.93%-8.42M
----
----
-Less：Restructuring and merger&acquisition
----
----
---23.02M
----
----
----
----
--0
----
----
-Less:Impairment of capital assets
259.01%8.58M
----
-77.05%2.39M
----
----
--2.39M
----
--10.42M
----
----
-Gain on sale of business
----
----
--0
----
----
----
----
423.56%2M
----
----
Income before tax
14.72%51.29M
-3.31%45.17M
39.64%212.07M
202.11%70.74M
13.37%49.92M
36.16%44.7M
-9.45%46.71M
7.40%151.87M
-28.24%23.41M
4.27%44.03M
Income tax
15.89%12.6M
33.55%11.14M
29.40%44.39M
318.64%12.76M
-2.85%12.42M
37.22%10.87M
-20.93%8.34M
31.94%34.31M
-6.04%3.05M
37.80%12.79M
Net income
14.34%38.68M
-11.32%34.03M
42.64%167.68M
184.68%57.98M
20.02%37.49M
35.82%33.83M
-6.50%38.37M
1.87%117.56M
-30.68%20.37M
-5.17%31.24M
Net income continuous Operations
14.34%38.68M
-11.32%34.03M
42.64%167.68M
184.68%57.98M
20.02%37.49M
35.82%33.83M
-6.50%38.37M
1.87%117.56M
-30.68%20.37M
-5.17%31.24M
Minority interest income
Net income attributable to the parent company
14.34%38.68M
-11.32%34.03M
42.64%167.68M
184.68%57.98M
20.02%37.49M
35.82%33.83M
-6.50%38.37M
1.87%117.56M
-30.68%20.37M
-5.17%31.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
14.34%38.68M
-11.32%34.03M
42.64%167.68M
184.68%57.98M
20.02%37.49M
35.82%33.83M
-6.50%38.37M
1.87%117.56M
-30.68%20.37M
-5.17%31.24M
Basic earnings per share
22.73%0.81
-5.33%0.71
43.53%3.33
193.91%1.1786
20.97%0.75
34.69%0.66
-7.41%0.75
2.20%2.32
-31.15%0.401
-4.62%0.62
Diluted earnings per share
22.73%0.81
-5.41%0.7
44.54%3.31
192.50%1.17
21.31%0.74
37.50%0.66
-7.50%0.74
2.23%2.29
-29.82%0.4
-4.69%0.61
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Sep 27, 2025(Q1)Jun 28, 2025(FY)Mar 29, 2025(Q4)Mar 29, 2025(Q3)Dec 28, 2024(Q2)Sep 28, 2024(Q1)Jun 29, 2024(FY)Mar 30, 2024(Q4)Mar 30, 2024(Q3)Dec 30, 2023
Total revenue -5.27%327.32M-4.40%321.39M3.95%1.36B-3.70%330.6M3.66%348.54M8.59%345.51M7.98%336.17M12.01%1.31B12.77%343.29M10.14%336.25M
Operating revenue -5.27%327.32M-4.40%321.39M3.95%1.36B-3.70%330.6M3.66%348.54M8.59%345.51M7.98%336.17M12.01%1.31B12.77%343.29M10.14%336.25M
Cost of revenue -16.13%132.57M-19.91%129.15M-0.91%611.87M-17.82%137.55M-2.14%155M7.04%158.07M11.93%161.25M11.55%617.51M12.97%167.38M8.04%158.38M
Gross profit 3.90%194.74M9.90%192.24M8.30%748.96M9.75%193.05M8.82%193.55M9.93%187.44M4.58%174.92M12.43%691.55M12.58%175.91M12.07%177.87M
Operating expense -4.26%127.67M2.37%138.37M5.70%547.77M3.49%142.35M1.99%134.52M-1.37%133.35M18.98%135.17M12.80%518.25M13.32%137.54M14.26%131.89M
Selling and administrative expenses -4.98%101.62M2.28%110.72M1.16%436.79M3.48%115.14M-4.70%106.46M-7.26%106.95M15.79%108.25M14.63%431.78M13.81%111.26M18.01%111.71M
Research and development costs 5.18%14.87M12.54%16.26M15.22%62.72M0.36%15.91M19.33%15.83M11.64%14.14M14.24%14.45M8.59%54.44M1.36%15.86M4.54%13.27M
Depreciation amortization depletion -8.82%11.18M-8.65%11.39M50.67%48.26M8.35%11.3M76.96%12.23M69.81%12.26M66.88%12.47M-1.87%32.03M30.74%10.43M-14.45%6.91M
-Depreciation and amortization -8.82%11.18M-8.65%11.39M50.67%48.26M8.35%11.3M76.96%12.23M69.81%12.26M66.88%12.47M-1.87%32.03M30.74%10.43M-14.45%6.91M
Operating profit 24.01%67.08M35.51%53.87M16.09%201.19M32.17%50.7M28.39%59.03M53.21%54.09M-25.91%39.76M11.34%173.3M10.00%38.36M6.24%45.98M
Net non-operating interest income expense -3.05%-7.21M-225.10%-8.7M25.13%-9.75M90.84%-598K-367.52%-9.11M-183.00%-6.99M436.25%6.96M11.02%-13.02M-148.35%-6.53M-84.74%-1.95M
Non-operating interest income --------------------------6.96M------------
Non-operating interest expense 3.05%7.21M--8.7M-25.13%9.75M-90.84%598K367.52%9.11M183.00%6.99M-----11.02%13.02M148.35%6.53M84.74%1.95M
Other net income (expense) -259.01%-8.58M345.05%20.63M-2.39M-2,303.93%-8.42M
Special income (charges) -259.01%-8.58M----345.05%20.63M-----------2.39M-----2,303.93%-8.42M--------
-Less：Restructuring and merger&acquisition -----------23.02M------------------0--------
-Less:Impairment of capital assets 259.01%8.58M-----77.05%2.39M----------2.39M------10.42M--------
-Gain on sale of business ----------0----------------423.56%2M--------
Income before tax 14.72%51.29M-3.31%45.17M39.64%212.07M202.11%70.74M13.37%49.92M36.16%44.7M-9.45%46.71M7.40%151.87M-28.24%23.41M4.27%44.03M
Income tax 15.89%12.6M33.55%11.14M29.40%44.39M318.64%12.76M-2.85%12.42M37.22%10.87M-20.93%8.34M31.94%34.31M-6.04%3.05M37.80%12.79M
Net income 14.34%38.68M-11.32%34.03M42.64%167.68M184.68%57.98M20.02%37.49M35.82%33.83M-6.50%38.37M1.87%117.56M-30.68%20.37M-5.17%31.24M
Net income continuous Operations 14.34%38.68M-11.32%34.03M42.64%167.68M184.68%57.98M20.02%37.49M35.82%33.83M-6.50%38.37M1.87%117.56M-30.68%20.37M-5.17%31.24M
Minority interest income
Net income attributable to the parent company 14.34%38.68M-11.32%34.03M42.64%167.68M184.68%57.98M20.02%37.49M35.82%33.83M-6.50%38.37M1.87%117.56M-30.68%20.37M-5.17%31.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 14.34%38.68M-11.32%34.03M42.64%167.68M184.68%57.98M20.02%37.49M35.82%33.83M-6.50%38.37M1.87%117.56M-30.68%20.37M-5.17%31.24M
Basic earnings per share 22.73%0.81-5.33%0.7143.53%3.33193.91%1.178620.97%0.7534.69%0.66-7.41%0.752.20%2.32-31.15%0.401-4.62%0.62
Diluted earnings per share 22.73%0.81-5.41%0.744.54%3.31192.50%1.1721.31%0.7437.50%0.66-7.50%0.742.23%2.29-29.82%0.4-4.69%0.61
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -